Last reviewed · How we verify
Copaiba
At a glance
| Generic name | Copaiba |
|---|---|
| Sponsor | Instituto Nacional de Cancer, Brazil |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Natural Product System and Lifestyle Modification (NA)
- Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy (PHASE1)
- Effect of an Experimental Gel Containing Copaiba Oil-resin in the Control of Dentin Hypersensitivity (NA)
- Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy (PHASE2)
- An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes (NA)
- The Effect of an Experimental Gel Based on Copaiba Oil Resin in Reducing Post-bleaching Tooth Sensitivity (NA)
- Essential Oil for Chronic Low Back Pain (NA)
- Stress Relief Properties of a Cosmetic Routine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Copaiba CI brief — competitive landscape report
- Copaiba updates RSS · CI watch RSS
- Instituto Nacional de Cancer, Brazil portfolio CI